TY  - JOUR
AU  - García Feijoo, Julián
AU  - Martínez De La Casa Fernández-Borrella, José María
AU  - Castillo, A
AU  - Méndez Hernández, Carmen Dora
AU  - Fernández Vidal, Ana María
AU  - García Sánchez, Julián
PY  - 2006
DO  - 10.1185/030079906X120959
UR  - https://hdl.handle.net/20.500.14352/107380
T2  - Current Medical Research and Opinion
AB  - Purpose: The primary objective of this study was to determine the intraocular pressure- (IOP) lowering efficacy over two consecutive 24-h periods of travoprost 0.004% ophthalmic solution (Travatan†) compared to latanoprost 0.005% (Xalatan‡) dosed once...
LA  - eng
M2  - 1689
PB  - Taylor & Francis
KW  - Glaucoma
KW  - Intraocular pressure
KW  - Latanoprost
KW  - Ocular hypertension
KW  - Prostaglandin
KW  - Travoprost
TI  - Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%
TY  - journal article
VL  - 22
ER  -